Spaulding Clinical Research, LLC Successful FDA Inspection

Press Release:

Spaulding Clinical Research, LLC Successful FDA Inspection 2018

November 06, 2018 -  Spaulding Clinical Research, LLC, a global clinical pharmacology, cardiac safety and biometrics solutions provider, announces the U.S. Food and Drug Administration (FDA) performed a routine inspection related to a specific clinical trial conducted in 2017. On the fifth and final day, the FDA auditor concluded that no observations or findings were identified and that all clinical trial results were well-organized and well-documented.

This is Spaulding Clinical’s first inspection for 2018 and this 5-Day FDA inspection is a great testament to the company’s investments in quality and talent.

 

Read Full Press Release >>

Event | Outsourcing in Clinical Trials New England

November 6-7 | Boston, MA  //  Booth #75

Event:  Outsourcing in Clinical Trials New England

Connect with Us on LinkedIn through the banner below:

Spaulding Clinical Research OCT New England 2018

Please stop by Booth #75 and say hi to the Spaulding Clinical Team. Spaulding's Phase I Clinic utilizes the world's only fully integrated, CDISC ODM certified eSource system in their Phase I clinic, enabling complete real-time data transparency and remote monitoring capabilities.
 
Stop by to see how Spaulding can leverage their solutions to save you on study costs while significantly speeding up your Phase I drug development.
  
For more information on Spaulding's Clinical Pharmacology Unit, Full Service Biometrics Group, or Cardiac Core Laboratory, please contact headquarters at 262-334-6020.

Spaulding Clinical Event Mar. 21 | ASCPT

March 21-23 | Orlando, FL  //  Booth #206

Event:  American Society for Clinical Pharmacology & Therapeutics

Connect with Us on LinkedIn through the banner below:

Spaulding Clinical Research Graphic Banner for ASCPT 2018

Please stop by Booth #206 and say hi to the Spaulding Clinical Team. Spaulding's Phase I Clinic utilizes the world's only fully integrated, CDISC ODM certified eSource system in their Phase I clinic, enabling complete real-time data transparency and remote monitoring capabilities.
 
Stop by to see how Spaulding can leverage their solutions to save you on study costs while significantly speeding up your Phase I drug development.
  
For more information on Spaulding's Clinical Pharmacology Unit, Full Service Biometrics Group, or Cardiac Core Laboratory, please contact headquarters at 262-334-6020.